Literature DB >> 30447078

Efficacy of nivolumab monotherapy against acral lentiginous melanoma and mucosal melanoma in Asian patients.

T Maeda1, K Yoshino1, K Nagai1, S Oaku1, M Kato1, A Hiura1, H Hata2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30447078     DOI： 10.1111/bjd.17434

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

Review 1.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

2.  Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy.

Authors:  Jeongshim Lee; Jee Suk Chang; Mi Ryung Roh; Minkyu Jung; Choong-Kun Lee; Byung Ho Oh; Kee Yang Chung; Woong Sub Koom; Sang Joon Shin
Journal:  Cancer Res Treat       Date:  2020-02-13       Impact factor: 4.679

3.  Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients.

Authors:  Xuan Wang; Yan Kong; Zhihong Chi; Xinan Sheng; Chuanliang Cui; Lili Mao; Bin Lian; Bixia Tang; Xieqiao Yan; Lu Si; Jun Guo
Journal:  Thorac Cancer       Date:  2019-03-12       Impact factor: 3.500

4.  Immune Checkpoint Inhibitors in Advanced Acral Melanoma: A Systematic Review.

Authors:  Qingyue Zheng; Jiarui Li; Hanlin Zhang; Yuanzhuo Wang; Shu Zhang
Journal:  Front Oncol       Date:  2020-12-03       Impact factor: 6.244

5.  Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.

Authors:  Prachi Bhave; Tasnia Ahmed; Serigne N Lo; Alexander Shoushtari; Anne Zaremba; Judith M Versluis; Joanna Mangana; Michael Weichenthal; Lu Si; Thierry Lesimple; Caroline Robert; Claudia Trojanello; Alexandre Wicky; Richard Heywood; Lena Tran; Kathleen Batty; Florentia Dimitriou; Anna Stansfeld; Clara Allayous; Julia K Schwarze; Meghan J Mooradian; Oliver Klein; Inderjit Mehmi; Rachel Roberts-Thomson; Andrea Maurichi; Hui-Ling Yeoh; Adnan Khattak; Lisa Zimmer; Christian U Blank; Egle Ramelyte; Katharina C Kähler; Severine Roy; Paolo A Ascierto; Olivier Michielin; Paul C Lorigan; Douglas B Johnson; Ruth Plummer; Celeste Lebbe; Bart Neyns; Ryan Sullivan; Omid Hamid; Mario Santinami; Grant A McArthur; Andrew M Haydon; Georgina V Long; Alexander M Menzies; Matteo S Carlino
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

6.  Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study.

Authors:  Irene M Shui; Xiao Qiao Liu; Qing Zhao; Seung Tae Kim; Yuan Sun; Jennifer H Yearley; Tasmiah Choudhury; Andrea L Webber; Clemens Krepler; Razvan Cristescu; Jeeyun Lee
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

Review 7.  Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review.

Authors:  Jiarui Li; Haoxuan Kan; Lin Zhao; Zhao Sun; Chunmei Bai
Journal:  Ther Adv Med Oncol       Date:  2020-05-18       Impact factor: 8.168

8.  Treatment and prognosis of primary malignant melanoma of the esophagus.

Authors:  Lei Cheng; Zheng-Ying Guo; Lei Lei; Wen-Xian Wang; Chun-Wei Xu; Mei-Yu Fang
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.